Minerva Neurosciences Falls as US FDA Declines to Approve Drug for Schizophrenia Symptoms Minerva Neurosciences Falls as US FDA Declines to Approve Drug for Schizophrenia Symptoms

Minerva Neurosciences said on Tuesday the U.S. Food and Drug Administration (FDA) has declined to approve its drug to regulate behavioral changes in patients with...Reuters Health Information
Source: Medscape Psychiatry Headlines - Category: Psychiatry Tags: Psychiatry Source Type: news